Results 201 to 210 of about 27,657 (222)

Effect of Rosiglitazone on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease

Circulation, 2010
Hertzel C Gerstein, Robert E Ratner, Hector M Garcia-Garcia   +2 more
exaly  

Gemfibrozil considerably increases the plasma concentrations of rosiglitazone

Diabetologia, 2003
Mikko Niemi, Janne T Backman, Mikko Neuvonen   +2 more
exaly  

Rosiglitazone short-term monotherapy lowers fasting and post-prandial glucose in patients with Type II diabetes

Diabetologia, 2000
P Raskin
exaly  

Rosiglitazon

Medisch-Farmaceutische Mededelingen, 2003
openaire   +1 more source

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

Lancet, The, 2009
Philip Home, Stuart J Pocock, Henning Beck-Nielsen   +2 more
exaly  

A Comparison of the Effects of Rosiglitazone and Glyburide on Cardiovascular Function and Glycemic Control in Patients With Type 2 Diabetes

Diabetes Care, 2002
Marc Rendell, Dandona Paresh
exaly  

Rosiglitazone and Outcomes for Patients With Diabetes Mellitus and Coronary Artery Disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial

Circulation, 2013
Manuel Lombardero, Saul Genuth, Thomas W Donner   +2 more
exaly  

Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of rosiglitazone

British Journal of Clinical Pharmacology, 1999
Stephen E Clarke, R J Chenery
exaly  

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial

Lancet, The, 2006
Hertzel C Gerstein, Jackie Bosch, Jonathan E Shaw   +2 more
exaly  

Differential Effects of Rosiglitazone and Metformin on Adipose Tissue Distribution and Glucose Uptake in Type 2 Diabetic Subjects

Diabetes, 2003
Kirsti Hällsten, F Lönnqvist, Tapio Viljanen   +2 more
exaly